United Guardian (UG) Research & Development (2014 - 2026)
United Guardian's Research & Development was $124,395 in Q2 2026, up 15.3% from $107,868 a year earlier and up 8.1% from the prior quarter.
Powered by 
Analysis
United Guardian (UG) Research & Development (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, United Guardian's Research & Development was $480,798 through Jun 30, 2026, up 3.5% year-over-year; for FY2025, it was $463,644, up 1.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
- In earlier years, Research & Development was $456,779 in FY2024 (-1.6%), $463,992 in FY2023 (-5.5%), $490,770 in FY2022 (+2.5%) and $478,642 in FY2021 (+6.1%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 7.0%.
- The best year-over-year quarter for Research & Development over five years was Q1 2022 (growth of 49.1%); the worst was Q1 2024 (a decline of 18.9%).
- Per Business Quant data, UG's Research & Development in the three quarters before Q2 2026 was $115,021 (Q1 2026), $124,278 (Q4 2025) and $117,104 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | United Guardian | 32.62 Mn | -1.89 Mn | 1.55 Mn | 124,395.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124,395.00 |
| Mar 31, 2026 | 115,021.00 |
| Dec 31, 2025 | 124,278.00 |
| Sep 30, 2025 | 117,104.00 |
| Jun 30, 2025 | 107,868.00 |
| Mar 31, 2025 | 114,394.00 |
| Dec 31, 2024 | 131,065.00 |
| Sep 30, 2024 | 111,072.00 |
| Jun 30, 2024 | 111,660.00 |
| Mar 31, 2024 | 102,982.00 |
| Dec 31, 2023 | 110,163.00 |
| Sep 30, 2023 | 98,141.00 |
| Jun 30, 2023 | 128,729.00 |
| Mar 31, 2023 | 126,959.00 |
| Dec 31, 2022 | 125,914.00 |
| Sep 30, 2022 | 120,924.00 |
| Jun 30, 2022 | 112,266.00 |
| Mar 31, 2022 | 131,666.00 |
| Dec 31, 2021 | 129,589.00 |
| Sep 30, 2021 | 130,742.00 |
API Access
United Guardian Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=UG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "UG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=UG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();